Insider buying
~$110K2,000 sh @ $55.05
Traded Feb 20, 2025 · filed 2 days later
The CEO of Bristol Myers Squibb paid $110K out of pocket for Bristol Myers Squibb shares. 1 other person at Bristol Myers Squibb bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Dec 31, 2024 (Q4 2024) · Filed Mar 5, 2025
10 tracked managers disclosed the same change for Q4 2024. From a 13F filed Mar 5, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
New
Compared with the manager's Q3 2024 13F
231,500
0.29%
Within the filing's reported positions, not the manager's total assets
10
For Q4 2024
Insider buying
Traded Feb 20, 2025 · filed 2 days later
The CEO of Bristol Myers Squibb paid $110K out of pocket for Bristol Myers Squibb shares. 1 other person at Bristol Myers Squibb bought some too, in the same month.
Insider buying
Traded Feb 14, 2025 · filed 6 days later
Bristol Myers Squibb's Chief Med.Offr.,Drug Dev. paid $100K out of pocket for Bristol Myers Squibb shares. 1 other person at Bristol Myers Squibb bought some too, in the same month.
Fund moves
72 tracked managers disclosed the same change for Q4 2024. From a 13F filed Feb 14, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.